Patent · US Active

Method of making oral dosage forms

US12390535B2 · kind B2 · utility

0Cited by

2References

17Claims

0Family size

Assignee

Universität Heidelberg · DE

Inventors

Philipp Uhl · Heidelberg, DE
Max Sauter · Heidelberg, DE
Walter-Emil HAEFELI · Neckargemünd, DE

Key dates

Filing date	Sep 27, 2019
Grant date	Aug 19, 2025
Priority date	—
Expiry date	Jan 8, 2043

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/6911
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a method of making an oral dosage form comprising the steps of reacting at least one cell penetrating peptide (CPP), purifying CPP-lipid conjugates, processing a lipid batch to obtain CPP-modified liposomes and incorporating a liposome lyophilisate into an oral dosage form. The present invention further relates to oral dosage forms and oral dosage forms for use in a therapeutic method.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.